Molecule Details
InChIKeySGEGOXDYSFKCPT-UHFFFAOYSA-N
Compound NameVilazodone
Canonical SMILESN#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)18
Pfam Stratification Cross-Family
Avg pChEMBL6.89
SourceChEMBL;BindingDB;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB06684
Drug NameVilazodone
CAS Number163521-12-8
Groups approved investigational
ATC Codes N06AX24
DescriptionVilazodone is a novel compound with combined high affinity and selectivity for the 5-hydroxytryptamine (5-HT) transporter and 5-HT(1A) receptors[Label,A177622]. Vilazodone may also be associated with less sexual dysfunction and weight gain[A6947]. Vilazodone was given FDA approval on January 21, 201...

Categories: Agents that produce hypertension Antidepressive Agents Antidepressive Agents Indicated for Depression Benzofurans Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (moderate) Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Heterocyclic Compounds, Fused-Ring Indoles Membrane Transport Modulators Nervous System Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Piperazines Psychoanaleptics Psychotropic Drugs Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin 5-HT1 Receptor Agonists Serotonin Agents Serotonin Modulators Serotonin Receptor Agonists Serotonin antagonist and reuptake inhibitors (SARIs)
Cross-references: BindingDB: 50151982 ChEBI: 70707 CHEMBL439849 ChemSpider: 5293518 Drugs Product Database (DPD): 22626 D09698 PDB: YG7 PubChem:6918314 PubChem:175427083 RxCUI: 1086769 Wikipedia: Vilazodone ZINC: ZINC000001542113
Target Activities (18)
Target Gene Organism Category Pfam pChEMBL Type Source
P08908 HTR1A Homo sapiens Human PF00001 9.6 Ki ChEMBL;BindingDB
P31645 SLC6A4 Homo sapiens Human PF03491 PF00209 9.3 IC50 ChEMBL;BindingDB
Q99720 SIGMAR1 Homo sapiens Human PF04622 7.8 Ki ChEMBL
P41595 HTR2B Homo sapiens Human PF00001 7.2 Ki ChEMBL
P35462 DRD3 Homo sapiens Human PF00001 6.9 Ki ChEMBL
P23975 SLC6A2 Homo sapiens Human PF00209 6.8 IC50 ChEMBL;BindingDB
P35348 ADRA1A Homo sapiens Human PF00001 6.6 Ki ChEMBL
Q01959 SLC6A3 Homo sapiens Human PF00209 6.5 IC50 ChEMBL;BindingDB
P35367 HRH1 Homo sapiens Human PF00001 6.4 Ki ChEMBL
P28221 HTR1D Homo sapiens Human PF00001 6.4 Ki ChEMBL
P14416 DRD2 Homo sapiens Human PF00001 6.2 Ki ChEMBL;BindingDB
P25100 ADRA1D Homo sapiens Human PF00001 6.1 Ki ChEMBL
P35372 OPRM1 Homo sapiens Human PF00001 6.1 Ki ChEMBL
P34969 HTR7 Homo sapiens Human PF00001 6.1 Ki ChEMBL
P21917 DRD4 Homo sapiens Human PF00001 6.1 Ki ChEMBL
P50406 HTR6 Homo sapiens Human PF00001 6.0 Ki ChEMBL
P18505 GABRB1 Homo sapiens Human PF02931 PF02932 Clinical TTD_MultiTarget TTD_MultiTarget
P28222 HTR1B Homo sapiens Human PF00001 Clinical TTD_MultiTarget TTD_MultiTarget
DrugBank Target Actions (5)
Target Gene Target Name Action Type
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P10635 CYP2D6 Cytochrome P450 2D6 substrate enzymes
P33261 CYP2C19 Cytochrome P450 2C19 substrate enzymes
P08908 HTR1A 5-hydroxytryptamine receptor 1A agonist targets
P31645 SLC6A4 Sodium-dependent serotonin transporter inhibitor targets